Raleigh medical device firm Contego Medical lands $22.3M from investors
RALEIGH – Contego Medical, a Raleigh-based medical device firm that received FDA approval for two systems targeting neurovascular, coronary and peripheral vascular disease, has landed $22 million from 10 investors.
Contego disclosed the funding in an SEC filing.
In 2018, Conteo Medical received FDA approval for:
- The Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection.
- The “first” filter-based Integrated Embolic Protection (IEP) device, the Paladin Carotid PTA Balloon System.
Contego CEO Ravish Sachar signed the filing.
The company actually sought to raise $22.565 million but so far is some $215,000 short of that target.
In 2015 Contego raised more than $5 million.